Amgen Inc

AMGN

HealthcareNMS$190.8B

AMGN SEC filings last scanned 13 May 2026, 22:36 UTC

CEO Timeline

Robert A. BradwayCurrent

May 2012 — Present(14y)

Robert A. Bradway was appointed Chief Executive Officer of Amgen, effective May 23, 2012, succeeding Kevin W. Sharer.

4 source filings — click to expand

Kevin W. Sharer

Since at least Mar 2005 — May 2012(7y 2mo)

planned step down announced December 15, 2011

3 source filings — click to expand